The Wal-Mart owned e-commerce platform Flipkart is hosting Mobiles Bonanza sale that includes offers and discounts on plenty of smartphones, which are from brands like RealMe, Xiaomi, Asus and more. During the sale, buyers can also get an additional 10% discount on making payment through Axis bank debit or credit card. The offer is valid on EMI transactions as well. So, let’s begin. RealMe 2 Pro The RealMe 2 Pro, which is currently available on Flipkart at a starting price of Rs 12,990 will be available during the sale at a discounted price of Rs 11,990. The phone is powered by a Qualcomm Snapdragon 660 processor and features a 16MP sensor on the back. Check out the deal here. Xiaomi Redmi Note 6 Pro The Xiaomi Redmi Note 6 Pro is the first device by the Chinese manufacturer “Xiaomi” that features a total of four cameras- two on the back and two at the front. The phone was launched at an MRP of Rs 15,990. During the sale period, it will be available at a discounted price of Rs 12,999. Check out the deal here. Asus Zenfone Max Pro M2 The Asus Zenfone Max Pro M2 is one of the best mid-range devices that is currently available in the market. The phone is backed by the Qualcomm Snapdragon 660 processor and has a dual camera setup on the back. The phone will available during the sale at a price of Rs 11,999. Check out the deal here. Vivo V9 Pro The Vivo V9 Pro will also be available at a discount on Flipkart. The phone will be available for Rs 12,490 down from its MRP of Rs 17,990. The highlights of this device are its dual 13MP + 2MP rear camera and its 6.3-inch FHD+ display. Check out the deal here. Motorola One Power The Motorola One Power is a part of Google’s Android One program, which means the device will be the first one to receive updates directly from Google. The phone comes with a dual camera setup on the back and is powered by the Qualcomm Snapdragon 636 processor. During the sale, the device will be available for Rs 13,999. Check out the deal here.
from Latest Technology News http://bit.ly/2GOZeDd
No comments:
Post a Comment